Flohale Respules (Fluticasone Propionate)

Flohale Respules – Trusted Nebulised Fluticasone Therapy 

Breathing difficulties — particularly in very young children — demand treatment solutions that are both clinically effective and practically deliverable without demanding coordination, technique, or active cooperation that young patients simply cannot provide. Flohale Respules answer this challenge directly, offering nebulised fluticasone propionate suspension in a ready-to-use, unit-dose format that delivers proven inhaled corticosteroid therapy through calm, passive breathing — making effective daily preventer treatment genuinely accessible for infants, toddlers, and patients of all ages who struggle with conventional handheld inhaler devices.

At our online pharmacy, we stock genuine Flohale Respules products, giving patients and caregivers convenient, affordable, and reliable access to this trusted nebulised corticosteroid therapy — backed by professional pharmacy support and worldwide delivery.

What Are Flohale Respules?

Flohale Respules are single-dose, unit-dose plastic vials containing fluticasone propionate suspension for nebulisation. Each sealed vial contains a precise, pre-measured dose of fluticasone propionate — a potent synthetic inhaled corticosteroid widely regarded as one of the most effective anti-inflammatory respiratory medications available — suspended in a sterile aqueous solution ready for direct use in a standard nebuliser device.

Manufactured by Cipla — one of India’s most trusted and internationally recognised pharmaceutical companies — Flohale Respules are available in standard strengths designed to accommodate paediatric and adult dosing requirements across a range of asthma severity levels and prescribed treatment regimens.

The respule format provides a clinically significant practical advantage over conventional handheld preventer inhalers for specific patient populations — delivering fluticasone as a continuous fine aerosol mist through a nebuliser mask or mouthpiece during completely passive, normal breathing. No coordination, no inspiratory force requirements, no technique to master — just consistent, effective anti-inflammatory medication delivery with every breath throughout the treatment session.

How Do Flohale Respules Work?

Flohale Respules deliver fluticasone propionate — a highly potent synthetic glucocorticosteroid — directly into the airways through nebulised inhalation, combining the exceptional anti-inflammatory potency of fluticasone with the passive, effort-independent delivery advantages of nebuliser therapy.

Fluticasone Propionate’s Anti-inflammatory Mechanism — Fluticasone propionate is among the most potent inhaled corticosteroids currently available in clinical respiratory practice. It works by binding to glucocorticoid receptors with exceptionally high affinity in airway epithelial cells and inflammatory cells, triggering a comprehensive suppression of the inflammatory cascade that drives asthma and related respiratory conditions.

At the cellular level, fluticasone suppresses the recruitment and activation of key inflammatory cells including eosinophils, mast cells, basophils, and T-lymphocytes — simultaneously reducing the release of inflammatory mediators, cytokines, and chemokines that perpetuate airway inflammation. This multi-level anti-inflammatory action progressively reduces mucosal oedema, decreases mucus hypersecretion, and calms the chronically hypersensitive bronchial lining — transforming reactive, inflamed airways into stable, resilient ones with consistent regular use.

Fluticasone’s particularly high lipophilicity — its affinity for fatty tissues — means it remains localised within the airway tissue for extended periods after inhalation, prolonging its local anti-inflammatory effect while minimising systemic absorption and reducing the risk of whole-body corticosteroid side effects compared to oral steroid formulations.

Nebulised Delivery Mechanism — When the fluticasone suspension from a Flohale Respule is placed into a nebuliser chamber and the device is activated, it is converted into a continuous fine aerosol mist of microscopic medication particles. This mist is delivered continuously through a mask or mouthpiece over a five to ten-minute treatment session — allowing passive inhalation throughout normal, relaxed breathing without any coordination, technique, or active effort from the patient.

Who Benefits Most from Flohale Respules?

The nebulised respule format offers particular and sometimes irreplaceable clinical value for specific patient populations:

• Infants and Young Children — Babies and toddlers cannot coordinate handheld inhaler technique and cannot generate adequate inspiratory flow for dry powder devices. Nebulised fluticasone delivered through a soft face mask during passive breathing is often the only practical daily preventer delivery option for the youngest asthma patients
• Children During Acute Asthma Episodes — During acute episodes, children are too breathless and distressed to use handheld devices reliably. Nebulised therapy delivers medication continuously and effectively throughout the episode without demanding active patient cooperation
• Elderly Patients with Poor Inhaler Technique — Older patients who consistently struggle with conventional inhaler devices receive consistent, reliable fluticasone delivery through nebulisation without any technique demands or coordination requirements
• Patients with Neuromuscular Conditions — Individuals with conditions affecting breathing mechanics, hand strength, or coordination find nebulised therapy considerably more reliably accessible than any handheld device format
• Patients Requiring Higher or More Flexible Doses — Some patients with severe or poorly controlled asthma require higher fluticasone doses or more flexible dose adjustments than standard handheld inhalers conveniently allow — nebulised respule therapy provides this flexibility within a single treatment format
• Patients with Severe Airflow Limitation — Those with significantly compromised inspiratory capacity who cannot generate adequate flow for dry powder inhalers benefit from the flow-independent passive delivery that nebuliser therapy provides

Conditions Treated with Flohale Respules

Flohale Respules are prescribed for a range of inflammatory respiratory conditions across paediatric and adult patient populations:

• Persistent Asthma — Daily nebulised fluticasone provides consistent, potent anti-inflammatory preventer therapy for patients of all ages with persistent or moderate-to-severe asthma, particularly those unable to use conventional handheld preventer inhalers effectively
• Paediatric Asthma — The primary and most clinically important indication for nebulised fluticasone — providing safe, effective, age-appropriate daily preventer therapy for infants, toddlers, and young children with confirmed or suspected persistent asthma
• Severe Acute Asthma — Nebulised fluticasone contributes targeted anti-inflammatory support during and following severe acute asthma episodes, complementing bronchodilator nebuliser therapy for more comprehensive acute management
• Eosinophilic Airway Inflammation — Conditions characterised by eosinophilic inflammatory cell predominance respond particularly well to fluticasone’s potent targeted suppression of eosinophil recruitment and activation
• Allergic Asthma — Fluticasone’s broad anti-inflammatory action addresses the allergen-driven airway inflammatory cascade effectively — reducing allergen sensitivity and decreasing reactive airway responses to environmental triggers
• COPD with Inflammatory Features — In COPD patients with significant inflammatory components or overlapping asthma characteristics, nebulised fluticasone provides targeted anti-inflammatory airway support alongside bronchodilator maintenance therapy

Flohale vs Inhalex Respules – Key Differences

Benefits of Flohale Respules

• Exceptional anti-inflammatory potency — Fluticasone propionate is among the most potent inhaled corticosteroids available — delivering powerful, targeted airway inflammation control at relatively low doses
• Passive delivery requiring zero technique — Patients breathe normally throughout the treatment session — no coordination, no inspiratory force, no technique required
• Ideal for infants and young children — Provides the only practically viable daily preventer delivery option for the youngest asthma patients unable to use handheld devices
• Very low systemic absorption — Fluticasone’s high lipophilicity means it remains localised in the airway tissue — minimising systemic corticosteroid exposure and associated side effects
• Ready-to-use unit-dose convenience — Pre-measured sealed vials eliminate measuring errors, preparation steps, and contamination risk
• Compatible with standard home nebulisers — Works with widely available jet and mesh nebuliser machines without requiring specialist equipment
• Hygienic single-use format — Individually sealed vials ensure dose accuracy and prevent cross-contamination between treatment sessions
• Flexible dose strength options — Available strengths accommodate both paediatric maintenance dosing and adult higher-dose therapy requirements
• Consistent Cipla quality — Reliable pharmaceutical manufacturing standards ensure potency, purity, and dose accuracy with every product

How to Use Flohale Respules – Step-by-Step?

1. Wash hands thoroughly — Always wash hands before handling respule vials and nebuliser components
2. Assemble and inspect the nebuliser — Assemble your nebuliser device per manufacturer instructions, ensuring all components are clean and completely dry before use
3. Open the respule carefully — Twist the top of the sealed Flohale Respule vial and squeeze the entire contents into the nebuliser medication chamber
4. Dilute if instructed — If your doctor has prescribed dilution with sterile normal saline, add the specified volume — otherwise use the respule contents undiluted
5. Attach mask or mouthpiece — Connect the nebuliser chamber to the appropriate delivery interface — face mask for infants and young children, mouthpiece for older patients where possible
6. Position correctly — Seat the patient upright or slightly reclined — never flat — to maximise medication deposition in the lower airways
7. Begin the session — Switch on the nebuliser and encourage calm, relaxed, normal breathing throughout the full treatment session
8. Complete the full treatment — Continue until the nebuliser begins to splutter — typically five to ten minutes — indicating the medication has been fully delivered
9. Clean immediately after use — Rinse all nebuliser components thoroughly with clean water after every session and allow to air dry completely before storage

Important Usage Information

Daily Consistent Use Is Essential — Fluticasone is a preventer medication — its anti-inflammatory benefits depend entirely on regular, uninterrupted daily use. Missing sessions allows airway inflammation to return quietly — often without obvious warning symptoms until a significant episode occurs.

Use Immediately After Opening — Once a Flohale Respule vial is opened, use the entire contents immediately. Never store opened vials for later use — opened suspension is vulnerable to contamination and rapid potency degradation.

Never Mix Without Medical Confirmation — Only combine Flohale Respules with other nebuliser medications if specifically directed by your healthcare provider. Always confirm compatibility before mixing.

Rinse Mouth After Treatment — Older children and adults should always rinse their mouth with water and spit after each session to reduce oral thrush risk. For infants using a face mask, gently wipe the face with a damp cloth after treatment completion.

Keep Unopened Vials Correctly Stored — Store Flohale Respules at room temperature away from direct sunlight, heat, and freezing conditions. Keep vials in their original foil packaging until immediately before use.

Never Stop Without Medical Advice — Do not discontinue Flohale Respule therapy without first consulting your doctor. Sudden cessation causes rapid return of airway inflammation and can trigger significant deterioration in respiratory control.

Explore Asthma Inhaler Guides:- Asthma Inhalers: Types, Uses, Benefits & Complete Treatment Guide.

Frequently Asked Questions?

What are Flohale Respules used for?

Flohale Respules deliver nebulised fluticasone propionate for daily preventer therapy in persistent asthma — particularly in infants, young children, and patients unable to use conventional handheld inhalers effectively.

How are Flohale Respules different from Inhalex Respules?

Flohale contains fluticasone propionate, while Inhalex contains budesonide. Both are inhaled corticosteroids but differ in relative potency, available strengths, and specific clinical applications — your doctor will prescribe the most appropriate option for your needs.

How long does a Flohale Respule nebuliser session take?

A typical session takes five to ten minutes, continuing until the nebuliser chamber begins to splutter — indicating complete medication delivery.

Are Flohale Respules safe for infants?

Nebulised fluticasone is prescribed for paediatric patients including infants under specialist guidance. Always follow your paediatrician’s prescribed dose and treatment schedule precisely.

Can Flohale Respules be mixed with salbutamol nebuliser solution?

Some clinical protocols allow mixing — but always confirm compatibility and specific mixing instructions with your doctor or pharmacist before combining any nebuliser medications.

What should I do if my child does not cooperate with nebuliser treatment?

Try administering treatment during sleep when the child is calm. Using distraction techniques such as toys, screens, or storytelling during waking sessions can significantly improve cooperation and treatment completion.

Medical Disclaimer:-

The information provided on this page is for general informational purposes only and does not constitute medical advice, a clinical diagnosis, or a personalised treatment recommendation. Flohale Respules are prescription medications and must always be used under the direct guidance and supervision of a qualified healthcare professional. If you experience worsening respiratory symptoms, inadequate treatment response, or any unexpected side effects during nebulised fluticasone therapy, please seek medical attention promptly. Never adjust, discontinue, or substitute your prescribed nebuliser medication without first obtaining appropriate professional medical advice.

Similar Ingredients:-

Levolin Respules 0.31 Mg (Levosalbutamol)

Foracort Respules 0.5 Mg (Budesonide & Formoterol)

Duolin Respules (Levosalbutamol & Ipratropium)

Budecort Respules 0.5 Mg